Skip to main content
. 2015 Apr 27;290(24):14852–14865. doi: 10.1074/jbc.M115.638361

FIGURE 7.

FIGURE 7.

Antibodies raised against the C-terminal half of domain CR9 inhibit AgLDL-induced lipid droplet formation in human VSMCs. hVSMCs were preincubated with anti-P3 Abs (at 7.5 relative concentration) for 2 h and then exposed to AgLDL for a further 4 h. Confocal laser microscopy images showing BODIPY-stained lipid droplets (green dots) in anti-BSA- and anti-P3-treated hVSMCs. Scale bar, 25 μm.